This company listing is no longer active
TCR2 Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
TCR2 Therapeutics has a total shareholder equity of $226.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $308.0M and $81.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$206.24m |
Equity | US$226.26m |
Total liabilities | US$81.78m |
Total assets | US$308.04m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2K7's short term assets ($215.8M) exceed its short term liabilities ($38.6M).
Long Term Liabilities: 2K7's short term assets ($215.8M) exceed its long term liabilities ($43.2M).
Debt to Equity History and Analysis
Debt Level: 2K7 is debt free.
Reducing Debt: 2K7 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2K7 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 2K7 has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 36.5% each year.